- Home
- FF vs FDMT Comparison
FF vs FDMT Comparison
Compare FF & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FF
- FDMT
- Stock Information
- Founded
- FF N/A
- FDMT 2013
- Country
- FF United States
- FDMT United States
- Employees
- FF N/A
- FDMT N/A
- Industry
- FF Major Chemicals
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- FF Industrials
- FDMT Health Care
- Exchange
- FF Nasdaq
- FDMT Nasdaq
- Market Cap
- FF 176.1M
- FDMT 192.2M
- IPO Year
- FF N/A
- FDMT 2020
- Fundamental
- Price
- FF $3.62
- FDMT $7.26
- Analyst Decision
- FF
- FDMT Buy
- Analyst Count
- FF 0
- FDMT 9
- Target Price
- FF N/A
- FDMT $30.63
- AVG Volume (30 Days)
- FF 256.2K
- FDMT 2.5M
- Earning Date
- FF 08-11-2025
- FDMT 08-11-2025
- Dividend Yield
- FF 6.65%
- FDMT N/A
- EPS Growth
- FF N/A
- FDMT N/A
- EPS
- FF N/A
- FDMT N/A
- Revenue
- FF $165,860,000.00
- FDMT $33,000.00
- Revenue This Year
- FF N/A
- FDMT $11,586.49
- Revenue Next Year
- FF N/A
- FDMT N/A
- P/E Ratio
- FF N/A
- FDMT N/A
- Revenue Growth
- FF N/A
- FDMT N/A
- 52 Week Low
- FF $3.58
- FDMT $2.24
- 52 Week High
- FF $6.40
- FDMT $17.41
- Technical
- Relative Strength Index (RSI)
- FF 35.94
- FDMT 71.22
- Support Level
- FF $3.58
- FDMT $5.33
- Resistance Level
- FF $3.82
- FDMT $5.94
- Average True Range (ATR)
- FF 0.13
- FDMT 0.65
- MACD
- FF -0.04
- FDMT 0.18
- Stochastic Oscillator
- FF 6.25
- FDMT 91.71
About FF FutureFuel Corp. Common shares
FutureFuel Corp makes and sells diversified chemical products, bio-based fuel products, and specialty chemical products. The company is organized into two segments based on product type: biofuels and chemicals. The biofuel segment sells biodiesel and other petroleum products. Its fuels are made from a mix of diesel, vegetable oils, and grease feedstock. The chemicals segment sells products that are used in the production of agricultural chemicals, which include herbicides, coatings, and cleaning products, such as detergents.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.